콘텐츠로 건너뛰기
Merck
  • Meningeal fibrosarcoma: a case report and review of the literature.

Meningeal fibrosarcoma: a case report and review of the literature.

Acta neurologica Belgica (1992-01-01)
A Rovirosa, P Vicente, J Bellmut, S Morales, J M Del Campo, R Bodi, A Ortega
초록

Meningeal Fibrosarcoma (MF) accounts only for 0.5% of the brain tumors. Since the clinical manifestations and radiologic findings are non-specific, the diagnosis can only be achieved by pathological examination of surgically removed specimens. MF are tumors that behave locally very aggressively and respond poorly to treatment, with reported median survivals ranging from 6 to 15 months. We report a new case of MF describing the peculiar onset as a slow growing mass in scalp with bone destruction and without neurological clinical findings.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
Orientin, ≥97% (HPLC)